ChineseInvestors.com, Inc. (CIIX) On Target for Impressive

New Post Public Reply Private Reply Replies (0) Message Board
NetworkNewsWire
281
ChineseInvestors.com, Inc. (CIIX) On Target for Impressive Gains in CBD Healthcare Markets

- CIIX reported nearly 76 percent revenue growth for full year fiscal 2017
- Price target of $3.75 reflects investment potential of cannabis initiatives
- Recent launch of cryptocurrency daily Chinese video newscast from NYSE first of its kind
- CBD industry is expected to grow to $2.1 million in consumer sales by 2020 with $450 million coming from hemp-based sources

ChineseInvestors.com, Inc. (OTCQB: CIIX), a leading financial information website for Chinese-speaking investors in the United States, China and Canada, continues to innovate and create exceptional value opportunities with the launch of a CBD skincare line in China and a cryptocurrency daily Chinese video newscast from the NYSE. Notably, SeeThruEquity has updated and maintained its target price of $3.75 on shares of ChineseInvestors.com, Inc.’s stock.

Among the reported highlights is the company’s revenue growth of 75.9% over 2016, with revenues dramatically increasing in both its investor relations and subscription services segments (http://nnw.fm/nG6pX). CIIX’s business strategy of targeting the emerging cannabidiol (CBD) health products market includes bringing a new website online for its subsidiary ChineseCBDoil.com (http://nnw.fm/asKI9). This website offers the world’s first “CBD health products online store in the Chinese language.” At the same time, CIIX launched a Chinese language Yelp-style mobile application that contains a location-enabled database of recreational and medical marijuana dispensaries, as well as a platform to review and discuss various cannabis and CBD products.

The company’s wholly owned foreign subsidiary CBD Biotechnology recently completed the record filing process with the China Food & Drug Administration for its first retail line of hemp-infused skin care products. With this essential regulatory milestone met and several products designed and manufactured, ChineseInvestors.com is ready to promote and sell its CBD Hemp Oil and CBD infused skin care products in China, Alan Klitenic, CIIX director of investor relations said in a SmallCapVoice interview (http://nnw.fm/5V7jK).

Adding to the company’s robust growth pattern, the launch this week of the first cryptocurrency daily video newscast in the Chinese language from the NYSE is generating attention. Titled “Bitcoin Multimillionaire,” the video newscast aims to provide information and analysis regarding all aspects of the emerging digital currency world.

“Many Chinese investors are seeking information and education related to the cryptocurrency sector,” said Warren Wang, founder and CEO of CIIX said in a news release (http://nnw.fm/hHh0t). “Similar to U.S. stocks, as the price of digital currency, such as Bitcoin, continues to increase, Chinese people all over the world are taking notice and seeking access to timely information regarding market trends, news and analysis. We look forward to being the premier source for this information.”

Investors should also watch for CIXX to launch a website to serve the Chinese cryptocurrency investor. The new site, located at newcoin168.com, will seek to “be a leader in digital media and cryptocurrency and blockchain technology education,” providing straight forward explanations on all aspects of the cryptocurrency market while providing strategies and other opportunities to capitalize on this fast-paced financial industry.

For more information, visit the company’s website at www.ChineseInvestors.com

Please see full disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

Chineseinvestors.com Inc. (CIIX) Stock Research Links

CIIX Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Actinium Pharma Unveils Plans at Key Investor Conference

Updated Category News Views 2

Actinium Pharmaceuticals Steps into the Spotlight Alright, folks, here we have Actinium Pharmaceuticals, Inc. gearing up to make some noise at the H.C. Wainwright 28th Annual Global Investment Conference. This isn't just any roadshow—it's a chance to showcase the kind of pioneering work they're doing in targeted radiotherapies. With Sandesh Seth, the Chairman, taking...

Continue Reading
Dr. Rashedi Reveals Laughing Gas Safety for Kids

Updated Category News Views 0

Why Laughing Gas is a Game-Changer in Pediatric Dentistry You ever seen a kid freeze up like a deer in headlights at the dentist's office? I'm telling you, it's not just the sweet tooth nightmare but often the fear of that cold, intimidating chair. But let's talk about a game-changer: laughing gas or, known in the trade as nitrous oxide. Keeping Anxiety at Bay: The Role...

Continue Reading
Signant and Lothar Forge Future in Clinical Trials

Updated Category News Views 1

Breathing New Life into Clinical Trials Alright, folks, listen up. We've got a fresh collaboration cooking that could shake things up in the clinical trial sector. Signant Health, a heavyweight in clinical trial solutions, has teamed up with Lothar Medical, and they’ve hitched their wagons to launch something rather intriguing: the ALDS PRO pulmonary function tech. Let...

Continue Reading
2026 AI Talent Study Reveals Growth and Gaps

Updated Category News Views 2

Pushing Forward Yet Stumbling on the Details We've got a fresh scoop from the AI Leaders Council: They just rolled out their 2026 Corporate AI Talent Study. What's the big fuss? Well, they're tracking how companies are cozying up to artificial intelligence. Let's just say it's a mixed bag this time around. While almost everyone jumped on the AI bandwagon, only a scant 3%...

Continue Reading
Virterion Surges Ahead in VPS Racing With Reliable Hosting

Updated Category News Views 1

Why Virterion Stands Out in 2026 VPS Landscape For anyone knee-deep in the hosting game, you know the market's got more players than a late-night poker round. Virterion, though—that's a name carving out a noticeable niche, and for solid reasons. In 2026, the backdrop's not just speed, it’s about matching technology and support with what ambitious developers need. VPS...

Continue Reading
Patented Foodservice Firm's $1.6M Sale: High ROI Potential

Updated Category News Views 0

Cooking Up High Margins and Rapid Growth You don’t stumble on opportunities like this every day. A foodservice company out there is posting some mouth-watering numbers, and it’s shaking up the M&A scene. This one’s got patents holding up its brand like a culinary force field, and it’s now on the auction block for a cool $1.6 million. And the numbers? Well, they...

Continue Reading
XCOTTON Shines at IFA 2026: The New Horizon of Commerce

Updated Category News Views 1

Shifting Gears at the Checkout Counter Let's face it, we've all been there: you click, you pay, and then you wait. But what happens next is where brands often drop the ball. Sure, e-commerce has been all about getting us to trust the 'buy' button. That's where folks like XCOTTON are stepping up to the plate, giving us something else to consider. They were loud and clear...

Continue Reading
Dreame Unveils Vast AI Product Range at IFA 2026

Updated Category News Views 0

Overnight Sensation or Future Staple? I wonder if Dreame's top brass woke up sweating or smiling after their big reveal at IFA 2026. A buffet of over 100 products across 16 categories is no small feat, especially when you're banking on technologies developed over nine years. But let's cut through the noise—does this showcase promise innovation or just smoke and mirrors?...

Continue Reading
Inturai Ventures Closes Final Tranche with a Twist

Updated Category News Views 4

Wrapping Up a Wild Ride in the Investment Arena Markets are a fickle friend, and today we've got Inturai Ventures calling it a day on their latest cash grab. They've locked the final tranche of their private placement, pulling in an aggregate $963,713.70. Feels like they're counting pennies in this venture, but every cent counts when your aim is to shake up industries...

Continue Reading
AVEX Faces Lawsuit Over IPO Missteps

Updated Category News Views 3

Legal Storm Brewing with AEVEX's IPO Disclosures Whatever happened to straightforward honesty in business? AEVEX Corp. (NYSE: AVEX) might have forgotten that chapter judging by fresh allegations in their midst. Investors who bought AVEX Class A common stock between April 17 and June 4, 2026, have been hit with a curveball: a looming class action lawsuit for securities...

Continue Reading
ing Brands Faces Legal Probe; Fiduciary Duties Questioned"> Continue Reading